Piramal Life Sciences Q3FY11 revenue was at Rs 14 crore versus Rs 1.22 crore, YoY.
Its EBITDA loss was Rs 12.3 crore versus Rs 27 crore, YoY.
The company's net loss was Rs 25.6 crore versus Rs 36.7 crore, YoY.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!